- Q1 2024 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$25.04 (-3.36%)Earnings
- Q4 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2024$28.89 (-2.43%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Mirum Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023$28.39 (-0.11%)Earnings
- Mirum Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Mirum Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023$24.88 (-0.16%)Earnings
- Mirum Pharmaceuticals Inc To Acquire Travere Therapeutics Inc Call TranscriptJul 17, 2023
- Q1 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$27.85 (-2.59%)Earnings
- Q4 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 08, 2023$23.76 (-0.13%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$20.02 (-16.37%)Earnings
- Mirum Pharmaceuticals Inc To Discuss The Topline Data From the MARCH Study Call TranscriptOct 24, 2022
- Q2 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$26.05 (+11.80%)Earnings
- Q1 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$25.03 (+6.15%)Earnings
- Q4 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2022$22.8 (+7.55%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$15.49 (-2.46%)Earnings
- Mirum Pharmaceuticals Inc To Discuss FDA Approves LIVMARLI Call TranscriptSep 29, 2021
- Q2 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$14.54 (-0.62%)Earnings
- Q1 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$17.7 (-6.50%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Mirum Pharmaceuticals Inc Corporate Analyst Meeting TranscriptDec 09, 2020
Q3 2022 Mirum Pharmaceuticals Inc Earnings Call Transcript
Hello, everyone, and welcome to the Mirum Q3 2022 Business Update. My name is Emily, and I'll be coordinating your call today. (Operator Instructions) I'll now turn the call over to our host, Ian Clements, CFO of Mirum. Please go ahead, Ian.
Thanks, Emily, and good morning, everyone. I'd like to welcome you to Mirum Pharmaceuticals Third Quarter 2022 Conference Call. I'm joined today by our President and CEO, Chris Peetz, our Chief Operating Officer, Peter Radovich, our Head of R&D, Pam Vig, and Professor Richard Thompson from King's College London.
Earlier this morning, Mirum issued a news release announcing the company's results for the third quarter of 2022. Copies of this news release and SEC filings can be found in the Investors Section of our website.
Given that we have Professor Thompson on the call today to discuss the exciting full results from our Phase III MARCH-PFIC Study as presented earlier this week at AASLD, we intend to keep the rest of our updates brief.
Full
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)